Compare cetirizine gummy vs tablet in healthy adults
Part of Immune system & allergy clinical trials.
This Phase 1 study compares how a 10 mg cetirizine gummy absorbs in your body versus a 10 mg cetirizine tablet. The goal is to see whether the gummy works in a similar way, which may help confirm it’s reliably absorbed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be able to understand the study and give consent, and follow all visit instructions
- Be between 18 and 55 years old, and weigh over 110 lbs (50 kg) with BMI 18 to 32
- Be a non-smoker for at least 6 continuous months before starting
- Be willing to eat the full study breakfast (high-calorie, high-fat) within 30 minutes before each dose
- If you can become pregnant, have a negative pregnancy test and use birth control (or be surgically sterile or postmenopausal)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a higher dose of cetirizine (an allergy medicine) works better than the standard dose for treating sudden hives in adults. It may help people who have had new hives in the last day and are not taking certain other medicines.
This trial tests an injectable medication (cetirizine, a type of antihistamine) to see if it quickly relieves itching and hives in adults with acute (short-term) hives. It is for people whose hives have lasted less than 6 weeks and who still have bothersome symptoms.
This study tests how well the body absorbs a drug called zongertinib when it is given as tablets from two different manufacturers, with or without food. It helps researchers understand the best way to take the medicine.
This trial tests a new oral medication (GZC8072) in two groups: healthy people given a single dose, and people who are overweight or obese given multiple doses. The study aims to see if the drug is safe and how the body handles it, and may help with weight management.
This early-stage study tests how a new experimental medication (HSK55879) is tolerated and processed by the body in healthy volunteers. Researchers will also check how food affects the drug's absorption to help determine safe dosing for future patient studies.
This trial tests a new medicine called ZL-65, which may help treat certain conditions by reducing inflammation. It is a first-in-human study to see if the drug is safe and how the body handles it.
Hear when a new Allergy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.